DSIP vs Orforglipron
Overview
DSIP is primarily a sleep & recovery peptide, while Orforglipron is used for weight management & metabolic.
This page compares DSIP and Orforglipron across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| DSIP | Orforglipron | |
|---|---|---|
| Category | Sleep & Recovery | Weight Management & Metabolic |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 100-300 mcg | Clinical trials |
| Frequency | before bed | daily |
| Reported benefits | Improved deep sleep, stress reduction, recovery enhancement, pain reduction | Oral administration convenience, weight loss, glucose control |
| Reported side effects | Very well-tolerated, possible grogginess | Under investigation |
Key differences
Primary use. DSIP is categorised under Sleep & Recovery, while Orforglipron falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. DSIP: not FDA-approved; compounding permitted with a prescription as of April 2026. Orforglipron: FDA-approved.
Dosing. DSIP is typically dosed at 100-300 mcg (before bed). Orforglipron is typically dosed at Clinical trials (daily).
Can you stack them?
Some protocols combine peptides, but stacking DSIP and Orforglipron has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between DSIP and Orforglipron?
- DSIP is primarily a sleep & recovery peptide, while Orforglipron is used for weight management & metabolic. DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Orforglipron is FDA-approved for one or more indications.
- What is DSIP used for?
- Delta sleep-inducing peptide.
- What is Orforglipron used for?
- Oral GLP-1.
- Can you take DSIP and Orforglipron together?
- Some users combine peptides within a single protocol, but stacking DSIP and Orforglipron has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is DSIP or Orforglipron FDA-approved?
- DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026). Orforglipron is FDA-approved for one or more indications.
Read the full articles
- DSIP — full monograph: mechanism, research, dosing & references
- Orforglipron — full monograph: mechanism, research, dosing & references